2b labs Information

We turn seed-stage risk into Series A-ready investments. In DeepTech, the real bottleneck is no longer access to startups. It’s knowing when to invest, how to structure capital and how to turn investment into execution. At 2B Labs, we de-risk DeepTech companies between Seed and Series A, helping VC funds identify investment-ready opportunities, deploy capital more efficiently and support portfolio companies through critical growth milestones. We combine pre-investment analysis, milestone-based investment structuring and sector-specific post-investment support — aligning capital deployment with company maturity, commercial readiness and execution. Our approach follows three interconnected phases: Pre-Investment Analysis → Investment Decision & Structuring → Post-Investment Support ### What we do • Thesis-driven sourcing across 10+ European ecosystems • Investment readiness assessment beyond technical validation • Pre-investment analysis and structured investability reports • Investment decision support through VC Selection Committees • Investment entry timing and capital structuring • Milestone-based investment and capital deployment • Sector-specific go-to-market strategy and execution • Access to public funding and complementary financing • KPI-driven monitoring and milestone verification • Post-investment support to build commercial traction and scalability • Preparation for institutional funding and Series A readiness We develop sector-specific investment programmes across HealthTech and ClimateTech, combining dedicated VC investment mandates, pan-European sourcing, structured investment and hands-on execution, in collaboration with specialised partners and venture builders across Europe. ### Who we serve We work with two key players in the DeepTech investment ecosystem: • VC funds seeking to improve investment entry timing, capital efficiency, portfolio execution and risk-adjusted returns. • DeepTech startups with validated techno